CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-377

Something that has actually caught my eye recently, and that I don't think has been mentioned much here, is that highlighted bit about a "material improvement in the operating result in H2FY24". This sounds quite promising given the speculation around what the bottom line figure could given the increased investment in marketing, I assume it has been evident to them that the increase in sales has been substantially larger than any increase in expenses associated with the expansion, and that we should expect to see a continuation of the trend towards profitability. I'm quite excited for this late August results announcement